Literature DB >> 27921230

Upregulation of ROCK2 in gastric cancer cell promotes tumor cell proliferation, metastasis and invasion.

Manhua Li1,2, Jing Ke3, Qiuhong Wang4, Hongyan Qian5, Lei Yang6, Xunlei Zhang6, Jinzhang Xiao6, Haifang Ding1, Xiaohang Shan1, Qingqing Liu1, Ying Xiao1, Bojun Bao7, Hua Huang8.   

Abstract

Rho-associated coiled-coil-containing protein kinase 2 (ROCK2) has been known as an effector for the small GTPase Rho and plays an important role in tumor progression and metastasis. However, the effect of ROCK2 in gastric cancer (GC) has not been identified. This study showed that ROCK2 expression significantly increased in clinical GC tissues compared with adjacent non-cancer tissues. Immunohistochemistrical analysis showed that high expression of ROCK2 was correlated with tumor grade, tumor-node-metastasis stage, infiltration depth, lymph node invasion and Ki-67, and predicted poor prognosis in 135 gastric cancer specimens. In addition, we found that upregulated ROCK2 promoted proliferation, metastasis and invasion of GC cells, while ROCK2 knockdown led to the opposite results in vitro by Cell Counting Kit-8 (CCK-8) assay, colony formation assays, flow cytometric analysis and trans-well assays. Our findings supported that ROCK2 was a significant protein in the progress of GC and would provide a novel promising therapeutic strategy against human GC.

Entities:  

Keywords:  Gastric cancer; Invasion; Metastasis; Proliferation; ROCK2

Mesh:

Substances:

Year:  2016        PMID: 27921230     DOI: 10.1007/s10238-016-0444-z

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  24 in total

1.  ROCK-2 is associated with focal adhesion maturation during myoblast migration.

Authors:  K P Goetsch; C Snyman; K H Myburgh; C U Niesler
Journal:  J Cell Biochem       Date:  2014-07       Impact factor: 4.429

Review 2.  GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors.

Authors:  Kent L Rossman; Channing J Der; John Sondek
Journal:  Nat Rev Mol Cell Biol       Date:  2005-02       Impact factor: 94.444

3.  ROCK1 as a potential therapeutic target in osteosarcoma.

Authors:  Xianzhe Liu; Edwin Choy; Francis J Hornicek; Shuhua Yang; Cao Yang; David Harmon; Henry Mankin; Zhenfeng Duan
Journal:  J Orthop Res       Date:  2011-03-08       Impact factor: 3.494

4.  ROCKs are expressed in brain tumors and are required for glioma-cell migration on myelinated axons.

Authors:  Patrick Oellers; Uwe Schröer; Volker Senner; Werner Paulus; Solon Thanos
Journal:  Glia       Date:  2009-04-01       Impact factor: 7.452

5.  RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer.

Authors:  Ronil A Patel; Kara D Forinash; Roberta Pireddu; Ying Sun; Nan Sun; Mathew P Martin; Ernst Schönbrunn; Nicholas J Lawrence; Saïd M Sebti
Journal:  Cancer Res       Date:  2012-07-30       Impact factor: 12.701

6.  Overexpression of ROCK1 and ROCK2 inhibits human laryngeal squamous cell carcinoma.

Authors:  Junbo Zhang; Xue He; Yueying Ma; Yanli Liu; Huaiyin Shi; Weiwei Guo; Liangfa Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

7.  Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion.

Authors:  Carmen Chak-Lui Wong; Chun-Ming Wong; Edmund Kwok-Kwan Tung; Kwan Man; Irene Oi-Lin Ng
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

Review 8.  Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.

Authors:  Yi-Chia Lee; Tsung-Hsien Chiang; Chu-Kuang Chou; Yu-Kang Tu; Wei-Chih Liao; Ming-Shiang Wu; David Y Graham
Journal:  Gastroenterology       Date:  2016-02-02       Impact factor: 22.682

9.  Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.

Authors:  Kazumasa Fujitani; Han-Kwang Yang; Junki Mizusawa; Young-Woo Kim; Masanori Terashima; Sang-Uk Han; Yoshiaki Iwasaki; Woo Jin Hyung; Akinori Takagane; Do Joong Park; Takaki Yoshikawa; Seokyung Hahn; Kenichi Nakamura; Cho Hyun Park; Yukinori Kurokawa; Yung-Jue Bang; Byung Joo Park; Mitsuru Sasako; Toshimasa Tsujinaka
Journal:  Lancet Oncol       Date:  2016-01-26       Impact factor: 41.316

10.  ROCK1 & 2 perform overlapping and unique roles in angiogenesis and angiosarcoma tumor progression.

Authors:  J Montalvo; C Spencer; A Hackathorn; K Masterjohn; A Perkins; C Doty; A Arumugam; P P Ongusaha; R Lakshmanaswamy; J K Liao; D C Mitchell; B A Bryan
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

View more
  11 in total

1.  Substrate rigidity-dependent positive feedback regulation between YAP and ROCK2.

Authors:  Wataru Sugimoto; Katsuhiko Itoh; Yasumasa Mitsui; Takahiro Ebata; Hideaki Fujita; Hiroaki Hirata; Keiko Kawauchi
Journal:  Cell Adh Migr       Date:  2018-01-29       Impact factor: 3.405

2.  Circular RNA circ_HN1 facilitates gastric cancer progression through modulation of the miR-302b-3p/ROCK2 axis.

Authors:  Ding Wang; Xiaohui Jiang; Yi Liu; Guangxin Cao; Xueliang Zhang; Yuting Kuang
Journal:  Mol Cell Biochem       Date:  2020-09-19       Impact factor: 3.396

3.  ROCK2 disturbs MKP1 expression to promote invasion and metastasis in hepatocellular carcinoma.

Authors:  Yunyan Du; Shan Lu; Jin Ge; Dazhi Long; Chongyu Wen; Shengxing Tan; Leifeng Chen; Wei Zhou
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

4.  Genomic and Epigenomic Profile of Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMPs) Revealed Similarities and Differences with Leiomyomas and Leiomyosarcomas.

Authors:  Donatella Conconi; Serena Redaelli; Andrea Alberto Lissoni; Chiara Cilibrasi; Patrizia Perego; Eugenio Gautiero; Elena Sala; Mariachiara Paderno; Leda Dalprà; Fabio Landoni; Marialuisa Lavitrano; Gaia Roversi; Angela Bentivegna
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

5.  Down-Regulating HAUS6 Suppresses Cell Proliferation by Activating the p53/p21 Pathway in Colorectal Cancer.

Authors:  Aling Shen; Liya Liu; Yue Huang; Zhiqing Shen; Meizhu Wu; Xiaoping Chen; Xiangyan Wu; Xiaoying Lin; Youqin Chen; Li Li; Ying Cheng; Jianfeng Chu; Thomas J Sferra; Lihui Wei; Qunchuan Zhuang; Jun Peng
Journal:  Front Cell Dev Biol       Date:  2022-01-12

6.  Precise Identification of Recurrent Somatic Mutations in Oral Cancer Through Whole-Exome Sequencing Using Multiple Mutation Calling Pipelines.

Authors:  Li-Han Lin; Chung-Hsien Chou; Hui-Wen Cheng; Kuo-Wei Chang; Chung-Ji Liu
Journal:  Front Oncol       Date:  2021-11-29       Impact factor: 6.244

7.  Prognostic Value of Intratumor Metabolic Heterogeneity Parameters on 18F-FDG PET/CT for Patients with Colorectal Cancer.

Authors:  Xin Liu; Kun Xiang; Guang-Yong Geng; Shi-Cun Wang; Ming Ni; Yi-Fan Zhang; Hai-Feng Pan; Wei-Fu Lv
Journal:  Contrast Media Mol Imaging       Date:  2022-01-30       Impact factor: 3.161

8.  Overexpression of Rho-Associated Coiled-Coil Containing Protein Kinase 2 Is Correlated with Clinical Progression and Poor Prognosis in Breast Cancer.

Authors:  Hua Yi; Kun Wang; He Jin; Junfang Su; Yidan Zou; Qiao Li; Lina He; Xiaodong Liu; Biaoyan Du
Journal:  Med Sci Monit       Date:  2018-07-10

9.  mi-R4435-2HG promotes proliferation and inhibits apoptosis of cancer cells in ovarian carcinoma by upregulating ROCK2.

Authors:  Jinghui Hu; Li Wang; Wei Zhao; Yujie Huang; Zhe Wang; Heping Shen
Journal:  Oncol Lett       Date:  2019-12-11       Impact factor: 2.967

10.  circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2.

Authors:  Lei Peng; Huaiming Sang; Shuchun Wei; Yuanyuan Li; Duochen Jin; Xudong Zhu; Xuan Li; Yini Dang; Guoxin Zhang
Journal:  Mol Cancer       Date:  2020-11-05       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.